IN2014CH00151A - - Google Patents

Download PDF

Info

Publication number
IN2014CH00151A
IN2014CH00151A IN151CH2014A IN2014CH00151A IN 2014CH00151 A IN2014CH00151 A IN 2014CH00151A IN 151CH2014 A IN151CH2014 A IN 151CH2014A IN 2014CH00151 A IN2014CH00151 A IN 2014CH00151A
Authority
IN
India
Prior art keywords
bendamustine
relates
present
parenteral compositions
solution
Prior art date
Application number
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Podili Khadgapathi
Bandari Sreedhar
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Priority to IN151CH2014 priority Critical patent/IN2014CH00151A/en
Priority to PCT/IN2015/000015 priority patent/WO2015104720A2/fr
Publication of IN2014CH00151A publication Critical patent/IN2014CH00151A/en
Priority to US15/203,999 priority patent/US20160310598A1/en
Priority to US15/645,237 priority patent/US20170304451A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN151CH2014 2014-01-13 2015-01-12 IN2014CH00151A (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN151CH2014 IN2014CH00151A (fr) 2014-01-13 2015-01-12
PCT/IN2015/000015 WO2015104720A2 (fr) 2014-01-13 2015-01-12 Compositions parentérales de bendamustine
US15/203,999 US20160310598A1 (en) 2014-01-13 2016-07-07 Parenteral compositions of bendamustine
US15/645,237 US20170304451A1 (en) 2014-01-13 2017-07-10 Parenteral compositions of bendamustine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN151CH2014 IN2014CH00151A (fr) 2014-01-13 2015-01-12

Publications (1)

Publication Number Publication Date
IN2014CH00151A true IN2014CH00151A (fr) 2015-07-17

Family

ID=53524448

Family Applications (1)

Application Number Title Priority Date Filing Date
IN151CH2014 IN2014CH00151A (fr) 2014-01-13 2015-01-12

Country Status (3)

Country Link
US (2) US20160310598A1 (fr)
IN (1) IN2014CH00151A (fr)
WO (1) WO2015104720A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110772480B (zh) * 2016-03-25 2022-05-17 南京百劲企业管理咨询有限公司 苯达莫司汀药剂组合物及应用
EP3509569A1 (fr) * 2016-09-07 2019-07-17 Cadila Healthcare Limited Compositions stériles injectables comprenant médicament micellaires
US11730815B2 (en) 2018-11-26 2023-08-22 Good Health, Llc Stable liquid pharmaceutical compositions comprising bendamustine
JP2020090481A (ja) * 2018-11-27 2020-06-11 日本化薬株式会社 ベンダムスチンを含有する溶液製剤
WO2020170104A1 (fr) * 2019-02-18 2020-08-27 Shilpa Medicare Limited Compositions parentérales de bendamustine liquides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
AU2009296734B2 (en) * 2008-09-25 2016-02-18 Cephalon Llc Liquid formulations of bendamustine
US20100273730A1 (en) * 2009-04-27 2010-10-28 Innopharmax, Inc. Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof

Also Published As

Publication number Publication date
WO2015104720A3 (fr) 2015-11-26
WO2015104720A2 (fr) 2015-07-16
US20170304451A1 (en) 2017-10-26
US20160310598A1 (en) 2016-10-27

Similar Documents

Publication Publication Date Title
PH12016501763A1 (en) Multispecific antibodies
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
IL264454A (en) Novel compositions, uses and methods for making them
MX2017002969A (es) Composiciones detergentes que contienen un surfactante ramificado.
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
HRP20190107T1 (hr) Supstituirani 2,4 diamino-kinolin kao novi antikancerogeni agens
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
TR201910057T4 (tr) Kauçuk bi̇leşi̇mleri̇
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2017002633A (es) Composicion polimerica para capa de elemento de capa.
MX2017003344A (es) Composicion de polimero para capa de un elemento de capa.
PH12016501865A1 (en) Pyridine-2-amides useful as cb2 agonists
IL254618A0 (en) Improvements regarding sending messages in the group
IN2014MU00455A (fr)
SG10201900598TA (en) Factor viii formulation
HK1247927A1 (zh) 新型組合物、用途及其製備方法
IN2014CH00151A (fr)
IN2013MU01113A (fr)
IN2013MU03768A (fr)
UA104671U (uk) Застосування яктону як нейропротектора
MX2016016577A (es) Aleacion de fundicion de aluminio.
IN2014MU03184A (fr)
UA97937U (uk) Матеріал для інтерференційних покриттів
UA99992U (ru) 2-оксо-4-фенил-5-циано-1,2,3,4-тетрагидропиридин-6-тиолат n-метилморфолиния
IN2013CH00453A (fr)